Voting Results and Scrutinizers Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Limited held its 9th Annual General Meeting on September 30, 2025, at Secunderabad, Telangana. The company had 437 shareholders on record as of the cut-off date (September 23, 2025). Of the total 71.12 lakh shares, around 47.09 lakh shares (66.21%) were polled through e-voting and physical ballot. Two ordinary resolutions were tabled and both passed with overwhelming majority. Resolution 1 (adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025) was approved with 98.73% votes in favour and only 1.27% against (60,000 shares). Resolution 2 (re-appointment of Managing Director Mr. Dopesh Raja Mulakala, who retires by rotation) was approved with 98.44% in favour and 1.56% against (60,000 shares). The scrutinizer, Mr. Zoheb S Sayani of Sayani & Associates, certified the voting process as fair and compliant.
Both resolutions passed comfortably with promoters voting entirely in favour, indicating strong management continuity and no shareholder dissent on financials. The 60,000 dissenting votes from public shareholders are minor but worth noting as they consistently voted against both resolutions.